Share: Facebook Twitter LinkedIn
Activity Provided By:

American Academy of CME and Spire Learning

Optimizing Outcomes in Newly Diagnosed Multiple Myeloma: Integrating Anti-CD38 Monoclonal Antibody Therapy Into Clinical Practice

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of the multiple myeloma care team including hematologists, oncologists, oncology advanced practice providers (APPs), oncology nurses, and allied health professionals (AHPs), such as pharmacists, medical technologists, and diagnostic medical sonographers.

Program Overview
Although multiple myeloma (MM) remains incurable, recent advances in therapy have led to improved outcomes. Given the recently approved and emerging treatment options that offer the potential to improve progression-free and overall survival in newly diagnosed MM, selecting the optimal therapy for these patients can be challenging. Thus, this educational activity provides members of the care team with expert insights on recent clinical trials, including late-breaking findings from ASH 2021, to allow them to incorporate new treatment regimens appropriately and safely for the management of newly diagnosed MM.

Learning Objectives
Upon completion of this activity, participants should be better able to:

EXPLAIN the rationale for incorporating newer effective and well-tolerated agents into the frontline treatment of patients with MM
APPLY evidence-based recommendations for the integration of anti-CD38 monoclonal antibody therapy into the treatment of patients with newly diagnosed MM
IDENTIFY patients with newly diagnosed MM for whom treatment with an anti-CD38 monoclonal antibody-based therapeutic regimen would be appropriate
OUTLINE optimal management and reduce burden of treatment for patients with newly diagnosed MM undergoing treatment with anti-CD38 monoclonal antibody-based therapy

Expiration

Jan 14, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.5

Accreditation

ACCME, ANCC

Presenters / Authors / Faculty

Faith E. Davies, MBBCh, MRCP, MD, FRCPath
Nina Shah, MD

Sponsors / Supporters / Grant Providers

Sanofi Genzyme

Keywords / Search Terms

Relias LLC Relias, Free CME, Multiple myeloma, MM Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map